Medical Disposable Plastic Stainless Steel Syringe Needle

Product Description: 
 
1.Product: Syringe Needle
2.Scope of application: disposable use of  venous tranfusion , hypodermic injection in clinic
3.Sterilization: Steriled with E.O. gas. Non-toxic, Non-pyrogenic
4.Certifications:  CE 0197
                           ISO 9001.2000Quality Control System Identification
                           ISO13485-20032000Quality COntrol System Identification

5.Warns: single use only.,reuse is forbiden.stop use if the pack is damaged
6.Advantages:  Technical workers and machines 
                         Highly sharp needle points,light punture force,less pain to patient 
7.Others : OEM offered.The specific details we can do as the clients request
 












If you have any interested in our product, just contact me directly.


 
 

Product Description: 
 
1.Product: Syringe Needle
2.Scope of application: disposable use of  venous tranfusion , hypodermic injection in clinic
3.Sterilization: Steriled with E.O. gas. Non-toxic, Non-pyrogenic
4.Certifications:  CE 0197
                           ISO 9001.2000Quality Control System Identification
                           ISO13485-20032000Quality COntrol System Identification

5.Warns: single use only.,reuse is forbiden.stop use if the pack is damaged
6.Advantages:  Technical workers and machines 
                         Highly sharp needle points,light punture force,less pain to patient 
7.Others : OEM offered.The specific details we can do as the clients request
 












If you have any interested in our product, just contact me directly.


 
 

  1.Good safety of gelatin-free.The first lyophilized Varicella Vaccine, containing no gelatin from animals, invented and produced in China. Getting rid of gelatin from varicella vaccine can significantly decrease the ratio of anaphylaxis incidence .

2.Long validity period by good stability. The first approved varicella vaccine with 36 months of validity period in the world. Adopting BH-2 stabilizer with own IP rights (Chinese patent granted No.: ZL200910138411.6, International patent application No.: PCT/CN2009/001405) greatly enhances the stability of the product and ensures the validity period for 36 months under the storage condition.

3.Better protection with high titer and immune efficacy. It`s documented that compared with the varicella vaccine of low titer, high titer vaccine can reduce breakthrough cases by nearly 75%  in vaccination. Of all released batches of Varicella Vaccine from BCHT, the titers are not less than 10000 PFU/dose tested by National Institutes for Food and Drug Control.

Varicella Vaccine(Live)

Live Bioproducts Pharmaceutical,Live High Potency Medicine,Live Preventive Pharmaceutical,Varicella Biopharmaceutical Live

Changchun BCHT Biotechnology Co. , http://www.ccbcht.com